Virios Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch VIRI and buy or sell other stocks, ETFs, and their options commission-free!

About VIRI

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. 

CEO
Gregory Duncan, MBA
CEOGregory Duncan, MBA
Employees
12
Employees12
Headquarters
Alpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded
Founded
Employees
12
Employees12

VIRI Key Statistics

Market cap
7.41M
Market cap7.41M
Price-Earnings ratio
-0.30
Price-Earnings ratio-0.30
Dividend yield
—
Dividend yield—
Average volume
163.18K
Average volume163.18K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$29.28
52 Week high$29.28
52 Week low
$1.62
52 Week low$1.62

People also own

Based on the portfolios of people who own VIRI. This list is generated using Robinhood data, and it’s not a recommendation.
Zomedica
Nikola
SNDL
Ocugen, Inc
Cenntro Inc.
Ideanomics
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.